339 related articles for article (PubMed ID: 20601366)
1. Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Shima Y; Nakanishi K; Kamei K; Togawa H; Nozu K; Tanaka R; Sasaki S; Iijima K; Yoshikawa N
Nephrol Dial Transplant; 2011 Jan; 26(1):163-9. PubMed ID: 20601366
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Kamei K; Nakanishi K; Ito S; Saito M; Sako M; Ishikura K; Hataya H; Honda M; Iijima K; Yoshikawa N;
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Shima Y; Nakanishi K; Kaku Y; Ishikura K; Hataya H; Matsuyama T; Honda M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N;
Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Yoshikawa N; Ito H; Sakai T; Takekoshi Y; Honda M; Awazu M; Ito K; Iitaka K; Koitabashi Y; Yamaoka K; Nakagawa K; Nakamura H; Matsuyama S; Seino Y; Takeda N; Hattori S; Ninomiya M
J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy.
Kawasaki Y; Suzuki J; Sakai N; Etoh S; Murai H; Nozawa R; Suzuki H
Am J Nephrol; 2004; 24(1):147-53. PubMed ID: 14726626
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
Yoshikawa N; Nakanishi K; Ishikura K; Hataya H; Iijima K; Honda M;
Pediatr Nephrol; 2008 May; 23(5):757-63. PubMed ID: 18224343
[TBL] [Abstract][Full Text] [Related]
7. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N; Honda M; Iijima K; Awazu M; Hattori S; Nakanishi K; Ito H;
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
9. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
Kawasaki Y; Maeda R; Ohara S; Suyama K; Hosoya M
Pediatr Int; 2018 Feb; 60(2):162-167. PubMed ID: 29178575
[TBL] [Abstract][Full Text] [Related]
10. Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.
Kawasaki Y; Suyama K; Miyazaki K; Kanno S; Ono A; Suzuki Y; Sato M; Hashimoto K; Hosoya M
Nephrology (Carlton); 2014 Jul; 19(7):384-91. PubMed ID: 24646214
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy.
Kawasaki Y; Hosoya M; Suzuki J; Onishi N; Takahashi A; Isome M; Nozawa R; Suzuki H
Am J Nephrol; 2004; 24(6):576-81. PubMed ID: 15550753
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
Yoshikawa N; Ito H
Nephrol Dial Transplant; 1999 May; 14(5):1097-9. PubMed ID: 10344344
[No Abstract] [Full Text] [Related]
13. [Therapy in IgA nephropathy--when and how to do it].
Vas T; Kovács T; Késoi I; Sági B; Degrell P; Wittmann I; Nagy J
Orv Hetil; 2011 Dec; 152(51):2039-46. PubMed ID: 22130201
[TBL] [Abstract][Full Text] [Related]
14. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.
Kamei K; Nakanishi K; Ito S; Ishikura K; Hataya H; Honda M; Nozu K; Iijima K; Shima Y; Yoshikawa N;
Pediatr Nephrol; 2015 Jun; 30(6):961-7. PubMed ID: 25487669
[TBL] [Abstract][Full Text] [Related]
16. Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy.
Tanaka H; Waga S; Yokoyama M
Tohoku J Exp Med; 1998 Aug; 185(4):247-52. PubMed ID: 9865471
[TBL] [Abstract][Full Text] [Related]
17. A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
Moriya T; Nakazawa K; Itoh N; Shigematsu H; Higuchi M; Miyasaka M; Oguchi H
Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):423-30. PubMed ID: 1635288
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
Kaneko T; Arai M; Ikeda M; Morita M; Watanabe Y; Hirama A; Shimizu A; Tsuruoka S
Int Urol Nephrol; 2015 Nov; 47(11):1823-30. PubMed ID: 26433884
[TBL] [Abstract][Full Text] [Related]
19. Mesangial C4d Deposits in Early IgA Nephropathy.
Segarra A; Romero K; Agraz I; Ramos N; Madrid A; Carnicer C; Jatem E; Vilalta R; Lara LE; Ostos E; Valtierra N; Jaramillo J; Arredondo KV; Ariceta G; Martinez C
Clin J Am Soc Nephrol; 2018 Feb; 13(2):258-264. PubMed ID: 29146701
[TBL] [Abstract][Full Text] [Related]
20. Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: disappearance of mesangial IgA deposits following steroid-induced remission.
Cheng IK; Chan KW; Chan MK
Am J Kidney Dis; 1989 Nov; 14(5):361-4. PubMed ID: 2816928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]